Superior Biomarker quantification, with robust performance and high sensitivity.
From discovery to late phase clinical trail studies, Chimera Biotec is a highly experienced provider of ultra sensitive biomarker sample testing. We have a long track record of supporting trials specific to a wide range of disease areas including oncology and neurology (CNS), as well as inflammatory, infectious, and metabolic diseases. Virtually any matrix can be explored utilizing the Imperacer® platform's outstanding ability to maintain extreme sensitivity despite high sample dilution.
PD literature list
|Clinical Biomarker Quantification: Novel Tools for Pharmacodynamic Applications||request reprint|
|Challenges in Developing a Sensitive PD Assay–From Tool Selection to Technologies Evaluation||request reprint|